MAPT and Alzheimer disease: Previously, we found that a novel coumarin derivative, LM-031, displayed neuroprotective potential by up-regulating nuclear factor erythroid 2-related factor 2 (NRF2) and CREB expression in pro-aggregatory tau SH-SY5Y cells and hyperglycemic triple-transgenic AD mice [28].